That’s why we launched ADVANCE®, a new precision medicine platform that is transforming genetic and clinical data into new insights for the diagnosis and management complex health conditions.
Ariel goes beyond genetics to help providers better identify and treat patients with pancreatitis.
Most patients with a complex, chronic disorder, such as pancreatitis, don’t have a single cause for their disease. Each patient has a unique combination of genetic and environmental risk factors.
Our AI powered technology combines deep genetic sequencing with advanced analytics and evidence-based knowledge to provide genetic testing and a report that is actionable and easy to use.
Ariel analyzes a patient’s genetic data and integrates the patient’s medical history and current symptoms to provide a comprehensive view of the factors that may be contributing to current conditions.
Our genetic reporting provides genetic, biological markers along with evidence-based guidelines that are individualized to each patient.
ADVANCE® Precision Medicine Platform
ADVANCE® is a clinical decision support platform that simplifies diagnosis and informs more accurate treatment selection at the earliest signs of pancreatic diseases.
ADVANCE integrates an individual’s genetics, environment, and family and medical history to provide clinicians more actionable insights into complex diseases, including evidence-based knowledge for management and treatment options. Our AI powered technology combines deep genetic sequencing with advanced analytics and evidence-based knowledge to provide genetic testing and a report that is actionable and easy to use.
Integrates a patient’s symptoms and genetics with medical information and curated evidence-based clinical considerations.
Pre- and/or post-test genetic counseling if you need extra help with genetic testing.
Analyzes multiple risk factors that are disease causing rather than just assessing single gene risk factors.
Order and review test results, add medical team and request patient consent using our portal.
As an MD, I am frustrated with the lack of effective treatment for pancreatic diseases. As a PhD, I am excited about new breakthroughs in knowledge and possibilities for the future. As a member of the Ariel Team, I am thrilled to see science meet medicine to provide those future solutions – NOW!
Gain a better understanding of unknown risk factors and whether you have a genetic cause for your condition, or an increased genetic susceptibility to it.
Comprehensive genetic testing and pre- and/or post-test genetic counseling.
Timely diagnosis can prevent costly and invasive diagnostic procedures, and allow for intervention prior to reaching end-stage disease.
Easy-to-use & non invasive DNA collection is done at home and then sent to our lab for analysis.
Targeted next-generation DNA sequencing (NGS) enabling high-throughput and rapid results for clinical and research applications.
High-throughput, cost-effective genotyping and associated bioinformatics services for small to large-scale research-initiatives.
Multidisciplinary team of physicians, computer scientists, biologists, and bioinformaticians providing customized analysis of biological data from a wide variety of genotyping and sequencing platforms.
Ariel has been recognized by several organizations for it’s outstanding work in healthcare and technology.
You don’t have to be an expert in genetics.
We help you translate complex genetic data into a more personalized care plan. So, you can focus on optimal care instead of sifting through complicated genetic information.
Get started with Ariel’s advanced pancreatitis testing.
